Home › Trial NCT04762953
Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis
- Trial IDNCT04762953
- StatusActive Not Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorUniversity of California, Irvine
- Enrollment40
- Start date2021-02-18
- ConditionsGastric Cancer · Peritoneal Carcinomatosis · Gastroesophageal Junction Adenocarcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.